Statements (54)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:computer
|
gptkbp:affects |
gastrointestinal system
|
gptkbp:associated_with |
gptkb:multiple_endocrine_neoplasia_type_1
gptkb:pancreatic_cancer chronic gastritis neuroendocrine tumors |
gptkbp:caused_by |
gastrin-secreting tumor
|
gptkbp:clinical_trial |
genetic studies
ongoing research new treatment options |
gptkbp:common_misdiagnosis |
peptic ulcer disease
gastroesophageal reflux disease irritable bowel syndrome |
gptkbp:complication |
malnutrition
weight loss gastrointestinal bleeding |
gptkbp:condition |
gptkb:gastrinoma
hypergastrinemia |
gptkbp:demographics |
more common in adults
slightly more common in men |
gptkbp:diagnosis |
gptkb:MRI
CT scan variable endoscopy depends on tumor type gastrin level measurement |
gptkbp:financial_support |
gptkb:educational_resources
support groups online forums |
gptkbp:first_described_by |
Eugene Ellison
John Zollinger |
gptkbp:genetic_link |
MEN1 gene mutation
|
gptkbp:historical_significance |
first described in 1955
|
https://www.w3.org/2000/01/rdf-schema#label |
Zollinger-Ellison syndrome
|
gptkbp:prevalence |
rare
|
gptkbp:public_awareness |
health organizations
patient advocacy groups medical conferences |
gptkbp:research_areas |
endocrinology
oncology gastroenterology |
gptkbp:symptoms |
abdominal pain
diarrhea recurrent peptic ulcers |
gptkbp:treatment |
gptkb:pharmaceuticals
gptkb:surgery radiation therapy chemotherapy proton pump inhibitors somatostatin analogs |
gptkbp:bfsParent |
gptkb:Lansoprazole
gptkb:Prilosec gptkb:Ranitidine |
gptkbp:bfsLayer |
6
|